Department of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
PLoS One. 2023 Mar 13;18(3):e0282833. doi: 10.1371/journal.pone.0282833. eCollection 2023.
To evaluate the efficacy of Optical Coherence Tomography (OCT) for detecting cervical lesions in women with minor abnormal cytology results (atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL)).
A prospective study was conducted at gynecologic clinic from Mar 2021 to Sep 2021. The recruited women with cervical cytological findings of ASC-US or LSIL were inspected with OCT before colposcopy-directed cervical biopsy. The diagnostic performance of OCT, alone and in combination with high-risk human papillomavirus (hrHPV) testing were evaluated to detect cervical intraepithelial neoplasia of grade 2 or worse (CIN2+)/CIN3 or worse (CIN3+). The rate of colposcopy referral and the immediate risk of CIN3+ of OCT were calculated.
A total of 349 women with minor abnormal cervical cytology results were enrolled. For detection of CIN2+/CIN3+, the sensitivity and NPV of OCT were lower than those of hrHPV testing (CIN2+: 71.3% vs. 95.4%, 89.0% vs. 91.1%, P < 0.001; CIN3+: 75% vs. 93.8%, 96.5% vs. 95.6%, P < 0.001), but the specificity, accuracy and PPV were higher than those of hrHPV testing (CIN2+: 77.5% vs. 15.6%, 75.9% vs. 35.5%, 51.2% vs. 27.3%, P < 0.001; CIN3+: 69.4% vs. 13.6%, 69.9% vs. 20.9%, 19.8% vs. 9.9%, P < 0.001). OCT combined with hrHPV testing (CIN2+: 80.9%; CIN3+: 72.6%) showed higher specificity than that of OCT alone (P < 0.001). The colposcopy referral rate base on OCT classification was lower than that based on hrHPV testing (34.7% vs. 87.1%, P < 0.001). Patients with hrHPV-positive ASC-US and hrHPV-negative LSIL cytology, the immediate CIN3+ risk in OCT negative cases was less than 4%.
OCT alone or combination with hrHPV testing shows good performance for detecting CIN2+/CIN3+ in patients with ASC-US/LSIL cytology. OCT is an effective method for colposcopy triage in women with hrHPV-positive ASC-US and hrHPV-negative LSIL cytology.
评估光学相干断层扫描(OCT)检测细胞学异常结果(不明确意义的非典型鳞状细胞(ASC-US)和低级别鳞状上皮内病变(LSIL))女性宫颈病变的疗效。
本前瞻性研究于 2021 年 3 月至 2021 年 9 月在妇科诊所进行。对宫颈细胞学检查发现 ASC-US 或 LSIL 的女性进行 OCT 检查,然后行阴道镜指导下宫颈活检。评估 OCT 单独及与高危型人乳头瘤病毒(hrHPV)检测联合应用检测 2 级或更高级别宫颈上皮内瘤变(CIN2+/CIN3+)/3 级或更高级别宫颈上皮内瘤变(CIN3+)的诊断性能。计算阴道镜转诊率和 OCT 即刻 CIN3+风险。
共纳入 349 例细胞学异常的女性。对于 CIN2+/CIN3+的检测,OCT 的敏感性和阴性预测值均低于 hrHPV 检测(CIN2+:71.3%比 95.4%,89.0%比 91.1%,P<0.001;CIN3+:75%比 93.8%,96.5%比 95.6%,P<0.001),但特异性、准确性和阳性预测值均高于 hrHPV 检测(CIN2+:77.5%比 15.6%,75.9%比 35.5%,51.2%比 27.3%,P<0.001;CIN3+:69.4%比 13.6%,69.9%比 20.9%,19.8%比 9.9%,P<0.001)。OCT 联合 hrHPV 检测(CIN2+:80.9%;CIN3+:72.6%)显示出比 OCT 单独检测更高的特异性(P<0.001)。基于 OCT 分类的阴道镜转诊率低于基于 hrHPV 检测(34.7%比 87.1%,P<0.001)。对于 hrHPV 阳性的 ASC-US 和 hrHPV 阴性的 LSIL 细胞学患者,OCT 阴性病例的即刻 CIN3+风险小于 4%。
OCT 单独或联合 hrHPV 检测对 ASC-US/LSIL 细胞学患者检测 CIN2+/CIN3+具有良好的性能。对于 hrHPV 阳性的 ASC-US 和 hrHPV 阴性的 LSIL 细胞学患者,OCT 是一种有效的阴道镜检查分类方法。